We’re doing something different here. We lead from the heart, and that makes your and our days that much nicer. What’s super nice (and rare) is you’ll have the most helpful of neighbors. Supera building Supers live on-site 24 / 7 in most of our buildings.
Supera Anesthesia Innovations, formerly LEI Medical, is an Oregon based company that produces medical anesthesia equipment for the veterinary field. Since 1993, the company has consistently improved the safety and quality of veterinary medical equipment and has recently expanded its manufacturing capabilities with a new leading-edge facility.
Abbott’s Supera™ Peripheral Stent, unique in its ability to flex and bend in dynamic vessel environments, offers much greater compression resistance than other standard nitinol stents.
Specifically, the Supera stent treats blockages in the superficial femoral artery (SFA), a blood vessel in the thigh, and the proximal popliteal artery (PPA), a blood vessel above the knee.
We set forth to analyze publicly reported adverse events in the FDA Manufacturer and User Facility Device Experience (MAUDE) database to better characterize predominant device and patient issues reported for the Supera Stent System.
Supera Stent System: What Is MAUDE Telling Us About This Novel ...
Since the 1950s, countless Chicagoans have made a Supera apartment their first home as they begin city life. The Supera building you’ll call home, today, preserves the historic architecture that gives our neighborhoods their charm.
Supera stent ordering information including key stent characteristics, stent technical parameters and available Supera stent diameters and lengths.
The Supera Peripheral Stent System is indicated to improve luminal diameter in the treatment of patients with symptomatic de novo or restenotic native lesions or occlusions of the superficial femoral artery (SFA) and/or proximal popliteal artery with reference vessel diameters of 4.0 to 6.5 mm, and lesion lengths up to 140 mm.